about
A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanomaRegulation and localization of endogenous human tristetraprolinPolymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis.Towards an understanding of the role of DNA methylation in rheumatoid arthritis: therapeutic and diagnostic implicationsBio-imaging and Photodynamic Therapy with Tetra Sulphonatophenyl Porphyrin (TSPP)-TiO2 Nanowhiskers: New Approaches in Rheumatoid Arthritis TheranosticsComparative persistence of the TNF antagonists in rheumatoid arthritis--a population-based cohort studyMultifocal Colonic Wall Abscesses during Anti-Tumor Necrosis Factor (TNF)-α Therapy for a Patient with Ulcerative Colitis: A Very Rare Manifestation of Infectious Complications.Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety.Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion.Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies.Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritisIncreased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis.Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritisGolimumab: A novel human anti-TNF-alpha monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis.Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis.Clinical use of anti-TNF therapy and increased risk of infectionsActive immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis.Treating rheumatoid arthritis with new disease modifying drugs.Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis.Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis.Subcutaneous bioavailability of golimumab at 3 different injection sites in healthy subjects.Divergent mechanisms of action of the inflammatory cytokines interleukin 1-beta and tumour necrosis factor-alpha in mouse cremasteric venulesImmunosenescence and rheumatoid arthritis: does telomere shortening predict impending disease?Adalimumab - a new TNF-alpha antibody for treatment of inflammatory joint disease.TNF-α and TNF-β Gene Polymorphism in Saudi Rheumatoid Arthritis Patients.Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis.Identification of transactivation-responsive DNA-binding protein 43 (TARDBP43; TDP-43) as a novel factor for TNF-α expression upon lipopolysaccharide stimulation in human monocytes.ICAM-1, E-selectin, and TNF alpha expression in labial salivary glands of patients with rheumatoid vasculitisBiodistribution of etanercept to tissues and sites of inflammation in arthritic rats.Perpetuation of inflammation associated with experimental arthritis: the role of macrophage activation by neutrophilic myeloperoxidase.The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis populationRheumatoid arthritis and genetic markers in Syrian and French populations: different effect of the shared epitope.Interleukin-17: the missing link between T-cell accumulation and effector cell actions in rheumatoid arthritis?Dynamics of early synovial cytokine expression in rodent collagen-induced arthritis : a therapeutic study using a macrophage-deactivating compound.Prohibitin as a novel autoantigen in rheumatoid arthritis.Efficacy of etanercept for treating the active rheumatoid arthritis: an updated meta-analysis.Current and new antitumor necrosis factor agents in perspective
P2860
Q21245488-3ADEC055-2E22-4CE8-99B1-2D3CF4B9D1FAQ24805049-5AF07731-72EA-46AF-B577-BCA4B933D1FCQ24812785-E6F2A495-7284-4C14-85E3-1CBB56251CB1Q24816519-0A7F8DEC-17C8-4D2A-A0CE-AC68786FC696Q26783490-2AF821AA-608C-49EB-B3C2-7C7B30C9E126Q27308865-7CBAFE1F-9F56-4A4E-B4CD-B324C00F8BEEQ28542423-FC53B378-C88B-438E-911A-FEBF8BF0C8AAQ32182441-CD73610F-E9AB-4ACB-AC63-D6155EF94569Q33328963-2D1E1AB5-46C6-4DFE-8A02-3AC069149729Q33578141-E792236E-055D-4590-A991-BA0740C5B6E0Q33578511-1BE54D74-7B64-476C-8C07-1F8E23756CE2Q33578865-0F88E5C1-0270-4906-AEE9-7150FACE7292Q33579339-0A2E8770-809A-44C3-93BE-137E49B4D91EQ33655250-27AAABAD-F223-4D17-BC99-BA52A5928A4CQ33708846-0210CD88-962D-43D2-8223-A77CF82044B9Q33782315-E3C113B6-6E51-42AC-9EF6-AF055B626057Q33973884-126A037F-B184-4595-A4C6-21479ACAA75DQ34119021-FFC3AB12-1D7B-4EC1-8228-F94BDDF816B2Q34338096-F11FD69D-4F00-4CE9-9DCB-36CB3608B2AEQ34413235-177C1617-3C01-46B3-95A7-BC23FE6B87ABQ34567932-7F554921-6A19-4841-9AC1-92C3D55C3FA6Q34576320-53EF4D14-2284-45CF-81C6-C343CF35DE30Q34613489-0C31BB29-C6DA-4BF3-BB85-2EFD9B66B6CCQ34614211-F5F8DD69-624A-4C4B-9196-EAEA08FD2902Q35044815-5889298F-FF9C-418E-AE6E-DAFBFC525C01Q35059538-184242FC-16B3-4245-8071-DF4475ECCE06Q35093636-B577106F-71E3-4855-AA63-C0AF9B152189Q35117732-45BF2017-4012-4C0A-861C-C1BDDB503DD3Q35132863-DF0936BF-D9A9-40B6-992F-8758638B72B2Q35244113-532705CA-FC0B-4DB6-B8DC-E7EBE41432E3Q35546880-4D1A3DEA-6395-4910-B72F-BF702A59BED2Q35600264-A23ED34D-FBCE-4D7C-B986-38C3822912A5Q35609907-3DD9132C-586B-48A0-ABAA-C9A6EE135496Q35636836-BA1215AD-3CC6-4AC5-9EDD-51CAD2FF65EEQ35638646-4A263C6B-5617-4EEE-ADE1-668685009CB7Q35675887-DE5EDE84-BC34-4A72-BC21-D18CE09B0FB5Q35746217-2BED1225-A068-4CB0-951E-98694840C916Q35756313-DF5C8D93-8D79-4950-BAA1-8BBA7030A595Q35768542-B1071A0D-308F-4945-A48F-17A18B65A4DEQ35823636-6D1093D2-EC96-4A5A-AFAA-963148D8AEC1
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
TNF alpha--a pivotal role in rheumatoid arthritis?
@ast
TNF alpha--a pivotal role in rheumatoid arthritis?
@en
type
label
TNF alpha--a pivotal role in rheumatoid arthritis?
@ast
TNF alpha--a pivotal role in rheumatoid arthritis?
@en
prefLabel
TNF alpha--a pivotal role in rheumatoid arthritis?
@ast
TNF alpha--a pivotal role in rheumatoid arthritis?
@en
P2093
P356
P1476
TNF alpha--a pivotal role in rheumatoid arthritis?
@en
P2093
P304
P356
10.1093/RHEUMATOLOGY/31.5.293
P577
1992-05-01T00:00:00Z